4-39446922-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_175737.4(KLB):c.2196C>G(p.Pro732Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.761 in 1,604,292 control chromosomes in the GnomAD database, including 464,893 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.75 ( 43310 hom., cov: 35)
Exomes 𝑓: 0.76 ( 421583 hom. )
Consequence
KLB
NM_175737.4 synonymous
NM_175737.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.24
Publications
19 publications found
Genes affected
KLB (HGNC:15527): (klotho beta) Enables fibroblast growth factor binding activity and fibroblast growth factor receptor binding activity. Predicted to be involved in fibroblast growth factor receptor signaling pathway. Predicted to act upstream of or within positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway and positive regulation of cell population proliferation. Predicted to be located in plasma membrane. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 4-39446922-C-G is Benign according to our data. Variant chr4-39446922-C-G is described in ClinVar as Benign. ClinVar VariationId is 1542991.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KLB | NM_175737.4 | c.2196C>G | p.Pro732Pro | synonymous_variant | Exon 4 of 5 | ENST00000257408.5 | NP_783864.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KLB | ENST00000257408.5 | c.2196C>G | p.Pro732Pro | synonymous_variant | Exon 4 of 5 | 1 | NM_175737.4 | ENSP00000257408.4 |
Frequencies
GnomAD3 genomes AF: 0.753 AC: 114506AN: 152136Hom.: 43272 Cov.: 35 show subpopulations
GnomAD3 genomes
AF:
AC:
114506
AN:
152136
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.768 AC: 182514AN: 237584 AF XY: 0.767 show subpopulations
GnomAD2 exomes
AF:
AC:
182514
AN:
237584
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.761 AC: 1105605AN: 1452038Hom.: 421583 Cov.: 77 AF XY: 0.762 AC XY: 550377AN XY: 722588 show subpopulations
GnomAD4 exome
AF:
AC:
1105605
AN:
1452038
Hom.:
Cov.:
77
AF XY:
AC XY:
550377
AN XY:
722588
show subpopulations
African (AFR)
AF:
AC:
23984
AN:
33444
American (AMR)
AF:
AC:
36814
AN:
44506
Ashkenazi Jewish (ASJ)
AF:
AC:
19351
AN:
25918
East Asian (EAS)
AF:
AC:
28942
AN:
39668
South Asian (SAS)
AF:
AC:
67464
AN:
85946
European-Finnish (FIN)
AF:
AC:
32451
AN:
45898
Middle Eastern (MID)
AF:
AC:
4119
AN:
5752
European-Non Finnish (NFE)
AF:
AC:
847071
AN:
1110660
Other (OTH)
AF:
AC:
45409
AN:
60246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
17122
34244
51365
68487
85609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20466
40932
61398
81864
102330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.753 AC: 114606AN: 152254Hom.: 43310 Cov.: 35 AF XY: 0.749 AC XY: 55801AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
114606
AN:
152254
Hom.:
Cov.:
35
AF XY:
AC XY:
55801
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
29832
AN:
41556
American (AMR)
AF:
AC:
12385
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
2639
AN:
3472
East Asian (EAS)
AF:
AC:
3822
AN:
5178
South Asian (SAS)
AF:
AC:
3796
AN:
4828
European-Finnish (FIN)
AF:
AC:
7413
AN:
10604
Middle Eastern (MID)
AF:
AC:
217
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52073
AN:
67996
Other (OTH)
AF:
AC:
1624
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1543
3086
4628
6171
7714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2751
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.